Profile of Autoimmune Connective Tissue Disorders in the University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria
DOI:
https://doi.org/10.60787/tnhj.v15i2.206Keywords:
Profile, Autoimmune, connective tissue disorders, Nigeria.Abstract
Background: Autoimmune Connective Tissue Disorders have rarely been reported among African blacks and even in Nigeria, in contrast with African-Americans. Our encounter with these cases shows that the disease may not be rare after all. The objective of this study was to report the prevalence, clinical presentations, laboratory and serological characteristics of patients presenting with autoimmune connective tissue disorders in the University of Port-Harcourt Teaching hospital.
Methods: This was a retrospective study of patients presenting with autoimmune disorder attending the Rheumatology and Dermatology clinic in University of Port Harcourt Teaching Hospital, Port Harcourt, located in Rivers state, South- South, Nigeria, over a period of one year (2012-2013). A review of the case records of all patients diagnosed and treated for autoimmune connective tissue disorders was utilized using the American College of Rheumatology Criteria for Systemic Lupus Erythematosus, Systemic Sclerosis and Rheumatoid Arthritis.
Results: Our study indicates that out of 931 Rheumatology/Dermatology cases seen, 30 were autoimmune connective disorders indicating a frequency of 3.2%. Out of this 3.2%, Systemic lupus erythematosus (SLE) constituted about 91%, rheumatoid arthritis 6% and systemic sclerosis constituted about 3%. The age range of the subjects was between 14-59years with a mean age of 34years indicating the universal young age at presentation. Females constituted females 93.3% of the patients with a female to male ratio of 14:1. The duration of disease ranged from (0.1-15 years) with a mean of 5years. The most clinical presentation of systemic lupus was discoid rash constituting about 93%, while that from rheumatoid arthritis was deformities of the proximal interphalangeal and distal interphalangeal joints. The major causes of mortality for the SLE patients were lupus nephritis, congestive cardiac failure and pulmonary hypertension, while death from systemic sclerosis was mostly linked to the renal crises. Rheumatoid factor was positive in 28 (93.3%), while Anti Neutrophilic Antibody was positive in 8 (26.6%) of the tested subjects.
Conclusion: Autoimmune disorders may not be uncommon in Port-Harcourt, Nigeria, contrary to previous reports, as both the prevalence and incidence are rising probably due to increasing awareness and better diagnostics. Age, gender and ethnicity may also account for the risk factors. This is the first study to report prevalence of autoimmune connective disorders in Port-Harcourt, Rivers State.
Downloads
References
Klippel J, Crofford L, Stone J, Weyand C, White P. Primer on Rheumatic Diseases. 13th edition New York springer 2008; Chapter 1.
Williams R. Autoimmune disease etiology- a perplexing paradox or a turning leaf? Autoimmunity reviews 2007; 6(4):204-208.
Mody GM. Rheumatoid arthritis and connective tissue disorders; Sub-saharan Africa. Bailliere's Clinical Rheumatology 1995;9(l):31-44.
Pons-Estel GJ, Alarcon GS, Lacie S, Leslie R, Glinda S. Understanding the epidemiology and progression of systemic lupus erythematosus. Seminars in Arthritis and Rheumatology 2010; 39:257-268.
Hochberg MC. The incidence of systemic lupus erythematosus in Baltimore. Arthritis Rheum 1985; 28(l):80-86.
Tikly M, Navarra S. Lupus in the developing world- is it any different? Best Pract. Res ClinRheumatol 2008; 22(4):643-55.
Molokhia M, McKeique P, Cuafrado M, Hughes G. Systemic lupus erythematosus in migrants from west Africa compared with Afro-Carribean people in the UK. Lancet 2001; 357(9266):1414-5.
Symmons D. Frequency of lupus in people of African origin. Lupus 1995; 4(3): 176-8.
Stein M, Davis P. Rheumatic disorders in Zimbabwe: a prospective analysis of patients attending a rheumatic diseases clinic. Ann Rheum Diseases 1990; 49(6):400-2
Malemba J, Mbuyi-Muamba M. Clinical and epidemiological features of rheumatic diseases in patients attending the university hospital in Kinshasa. Clinical Rheumatology 2008; 27 (1): 47¬54.
Adelowo O, Oguntona S. Pattern of systemic lupus erythematosus among Nigerians. Clinical Rheumatology 2009; 28(6):699-703.
Alan J, Jacqueline E. Epidemiology and genetics of rheumatoid arthritis. Arthritis research and therapy 2002; 4(3): 265-272
Adelowo O, Ojo O, Oduenyi I, Okwara C. Rheumatoid arthritis among Nigerians; the first 200 patients from a rheumatology clinic. Clinical rheumatology 2010; 29(6): 593-7
Silman A, Hochberg M, Cooper C. Epidemiology of rheumatic diseases. Oxford UK: Oxford University Press; 1993:192
Lawrence R, Helmick C, Arnett F. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998; 415:778-799.
Longo D, Fauci A, Hauser S, Dennis L, Dan L. Harrison principles of international medicine, New York, McGraw-Hill; 18th edition. 2012: Chapter 321.
Boin F, Wigley F. Clinical features and treatment of scleroderma. Kelley's textbook of Rheumatology, Philadelphia; 9th edition 2012: chapter 84.
Adelowo O, Oguntona S. Scleroderma (systemic sclerosis) among Nigerians. Clinical Rheumatology 2009;(28) 9:112-1¬5
Petri M, Orbai A, Alacron G. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheu 2012; 64(8):2677-86
Aletaha D, Neogi T, Silman A. Rheumatoid arthritis classification criteria: an American college of Rheumatology/ European League against Rheumatism collaborative initiative. Arthritis Rheu 2010; 62(9):2569-81
Park JS, Park MC,Song J, Park Y, Lee S, Lee S. Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients. Arthritis Res Ther. 2015; 17:77
Peschken C, Hitchon C. Rising prevalence of systemic autoimmune rheumatic disease; increased awareness, increased disease or increased survival? Arthritis research and therapy 2012; 14(3):20
Yu K, See L, KuoC,Chou I, Chou I. Prevalence and incidence in patients with autoimmune rheumatic diseases; a nationwide population-based study. Arthritis Care Res 2013;6592:244-50.
William E, Noel R, Amanda K, Marianne G, Preben M. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 2007; 29(1): 1-9
Ekwom P. Systemic lupus erythematosus(SLE) at the Kenyatta National Hospital. ClinRheumatol 2013; 32 (8):1215-7
Lahita RG, Leon B, Jack F, Henry G, Kunkel M. The role of sex hormones in systemic lupus erythematosus.Curropin Rheumatology 1999;ll(5);352-6
Shmerling R, Delbanco T. How useful is the rheumatoid factor and erythrocyte sedimentation rate? An analysis of senitivity and specificity and predictive valve. Arch Intern Med.l992;152: 2417¬2420
Solomon D, Kavanaugh A, Schur P. Evidence based guidelines for the use of immunologic tests. Antinuclear antibody testing. Arthritis Rheum 2002; 47:434¬-444
Marie D, Henry L, Gloria A, Helene E, Fernado K. Clinical presentation treatment and outcome of patients with SLE seen at a rheumatology clinic in Doula Cameroon. The journal of medicine and health sciences 2014; 15( 2):
Bertasias G, Loannidis J, Boletis J. EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheu Dis 2008; 67(2): 195-205
Wadee S, Tikly M, Hopley M, Chalmers A, Pellet F.Causes of predictors in South Africans with Systemic Lupus Erythematosus. Rheumatology 2007; 46 (9):1487-91
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 The Nigerian Health Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
